127 related articles for article (PubMed ID: 31629415)
1. Advances in germline genetics for prostate cancer funded by the Prostate Cancer Foundation.
Soule HR; Miyahira AK
Can J Urol; 2019 Oct; 26(5 Suppl 2):9. PubMed ID: 31629415
[TBL] [Abstract][Full Text] [Related]
2. Bringing Prostate Cancer Germline Genetics into Clinical Practice.
Das S; Salami SS; Spratt DE; Kaffenberger SD; Jacobs MF; Morgan TM
J Urol; 2019 Aug; 202(2):223-230. PubMed ID: 30730411
[TBL] [Abstract][Full Text] [Related]
3. The 27th Annual Prostate Cancer Foundation Scientific Retreat Report.
Miyahira AK; Soule HR
Prostate; 2021 Nov; 81(15):1107-1124. PubMed ID: 34469608
[TBL] [Abstract][Full Text] [Related]
4. The 24th Annual Prostate Cancer Foundation scientific retreat report.
Miyahira AK; Soule HR
Prostate; 2018 Sep; 78(12):867-878. PubMed ID: 29761524
[TBL] [Abstract][Full Text] [Related]
5. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
[TBL] [Abstract][Full Text] [Related]
6. Germline and Somatic Mutations in Prostate Cancer for the Clinician.
Cheng HH; Sokolova AO; Schaeffer EM; Small EJ; Higano CS
J Natl Compr Canc Netw; 2019 May; 17(5):515-521. PubMed ID: 31085765
[TBL] [Abstract][Full Text] [Related]
7. Germline testing in those at risk of prostate cancer.
Carroll PR; Witte JS; Parsons JK
Can J Urol; 2019 Oct; 26(5 Suppl 2):31-33. PubMed ID: 31629425
[TBL] [Abstract][Full Text] [Related]
8. Germline BLM mutations and metastatic prostate cancer.
Ledet EM; Antonarakis ES; Isaacs WB; Lotan TL; Pritchard C; Sartor AO
Prostate; 2020 Feb; 80(2):235-237. PubMed ID: 31816118
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer: germline prediction for a commonly variable malignancy.
Bambury RM; Gallagher DJ
BJU Int; 2012 Dec; 110(11 Pt C):E809-18. PubMed ID: 22974436
[TBL] [Abstract][Full Text] [Related]
10. Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer.
Isaacsson Velho P; Silberstein JL; Markowski MC; Luo J; Lotan TL; Isaacs WB; Antonarakis ES
Prostate; 2018 Apr; 78(5):401-407. PubMed ID: 29368341
[TBL] [Abstract][Full Text] [Related]
11. Germline testing for prostate cancer prognosis: implications for active surveillance.
Helfand BT; Xu J
Can J Urol; 2019 Oct; 26(5 Suppl 2):48-49. PubMed ID: 31629432
[TBL] [Abstract][Full Text] [Related]
12. The 22nd annual prostate cancer foundation scientific retreat report.
Miyahira AK; Simons JW; Soule HR
Prostate; 2016 Sep; 76(12):1037-52. PubMed ID: 27272144
[TBL] [Abstract][Full Text] [Related]
13. Germline genetics in localized prostate cancer.
Ryan ST; Nguyen V; Bree KK; Holst DD; Kader AK
Curr Opin Urol; 2019 Jul; 29(4):326-333. PubMed ID: 31116139
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of universal germline testing for men with prostate cancer in an Australian tertiary center.
Crumbaker M; Wong J; Joshua AM; Spigelman AD
Asia Pac J Clin Oncol; 2019 Aug; 15(4):257-261. PubMed ID: 31012270
[TBL] [Abstract][Full Text] [Related]
15. Urology perspective on the expanding world of germline testing for prostate cancer.
Cookson MS
Can J Urol; 2019 Oct; 26(5 Suppl 2):5-6. PubMed ID: 31629413
[TBL] [Abstract][Full Text] [Related]
16. No association of germline alteration of MSR1 with prostate cancer risk.
Wang L; McDonnell SK; Cunningham JM; Hebbring S; Jacobsen SJ; Cerhan JR; Slager SL; Blute ML; Schaid DJ; Thibodeau SN
Nat Genet; 2003 Oct; 35(2):128-9. PubMed ID: 12958598
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer in Cowden syndrome: somatic loss and germline mutation of the PTEN gene.
Barbosa M; Henrique M; Pinto-Basto J; Claes K; Soares G
Cancer Genet; 2011 Apr; 204(4):224-5. PubMed ID: 21536243
[No Abstract] [Full Text] [Related]
18. Prostate Cancer Screening in a New Era of Genetics.
Cheng HH; Pritchard CC; Montgomery B; Lin DW; Nelson PS
Clin Genitourin Cancer; 2017 Dec; 15(6):625-628. PubMed ID: 28697982
[TBL] [Abstract][Full Text] [Related]
19. The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real-world multicenter study.
Fei X; Fan L; Chen W; Chen W; Gong Y; Du X; Wang Y; Zhu Y; Pan J; Wang F; Zhao W; Liu T; Yang Y; Dong B; Xue W
Clin Transl Med; 2021 Oct; 11(10):e527. PubMed ID: 34709755
[No Abstract] [Full Text] [Related]
20. The 25th Annual Prostate Cancer Foundation Scientific Retreat Report.
Miyahira AK; Soule HR
Prostate; 2019 Sep; 79(12):1471-1486. PubMed ID: 31334865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
